At a glance
ClinicalIndex Comparison RecordN/ACompleted· 115,642 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of Non-invasive Risk Models for Prediction of Incident Type 2 Diabetes in a Swedish Population
In Brief
An observational study for Type2diabetes. Completed, enrolled 115,642 participants.
Detailed Summary
The goal of this observational study is to validate existing non-invasive diabetes clinical prediction models in a Swedish population. The main question it aims to answer is: how well 11 existing models will perform in predicting incident type 2 diabetes in participants from the Västerbotten Intervention programme (VIP). Participants in VIP are residents of Västerbotten that are invited for a comprehensive health screening at 30- (until 1995), 40-, 50-, and 60-years of age.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType2diabetes
Countries--
CollaboratorsUniversity of Cambridge
Timeline
N/ACompletedFinished
198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 1990
Primary CompletionDec 2020
First PostedNov 2022
TodayJul 2026
First PostedNov 8, 2022
Enrollment StartJan 1, 1990
Primary CompletionDec 1, 2020
TodayJul 2, 2026
Enrollment to primary: 30.9 yearsPosted 3.6 years ago